Professional
Added to YB: 2025-01-10
Pitch date: 2025-01-09
INMD [bullish]
InMode Ltd.
-6.81%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Market Cap
$943.7M
Pitch Price
$15.57
Price Target
21.32 (+47%)
Dividend
N/A
EV/EBITDA
3.83
P/E
6.51
EV/Sales
1.11
Sector
Health Care Equipment and Supplies
Category
turnaround
InMode Ltd.: Reshaping the Future of Aesthetics
INMD: Aesthetic device co facing cyclical pressures. Well-positioned for rebound w/ minimally invasive focus & weight loss drug trends. Diversifying via int'l expansion, new products & apps. Post-activist pressure, improved capital allocation w/ buybacks. Trading <2x cash, industry-leading margins. Risks: litigation, tech obsolescence.
Read full article (5 min)